A detailed history of Voya Investment Management LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 28,371 shares of ERAS stock, worth $61,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,371
Previous 34,299 17.28%
Holding current value
$61,848
Previous $73,000 20.55%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.67 - $2.55 $9,899 - $15,116
-5,928 Reduced 17.28%
28,371 $58,000
Q4 2023

Feb 14, 2024

BUY
$1.67 - $2.49 $2,580 - $3,847
1,545 Added 4.72%
34,299 $73,000
Q2 2023

Aug 14, 2023

BUY
$2.57 - $3.3 $17,039 - $21,879
6,630 Added 25.38%
32,754 $90,000
Q3 2022

Nov 14, 2022

BUY
$5.82 - $10.68 $8,537 - $15,667
1,467 Added 5.95%
26,124 $204,000
Q2 2022

Aug 15, 2022

BUY
$4.58 - $8.72 $112,929 - $215,009
24,657 New
24,657 $137,000

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $266M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.